 |
Magen BioSciencesMagen BioSciences is a specialty pharmaceutical company currently focused on developing proprietary medical therapies for the dermatology market. Magen's science-driven understanding of skin physiology leads to effective therapies for a number of skin disorders and the prevention of UV radiation related skin damage. The company has assembled an outstanding science, investor and management team. The team includes co-founders of Idexx, Immunex, Alnylam, Momenta, Vertex, Biogen and Genzyme. Recent NewsMagen Scientific Founder Named Chairman of Dermatology at MGHMagen BioSciences Licenses Dermatology Assets from LillyStudy in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor ProteinStudy in Nature by Magen BioSciences Co-Founder David E. Fisher Sheds New Light on the Pathway of Pigment Production in SkinMagen BioSciences Raises $15.4 Million in FundingMagen BioSciences, Inc. Announces Brian M. Gallagher Joins as President and CEO |
 CEOBrian M. Gallagher, Ph.D.Contact Info100 Beaver StreetSuite 101 Waltham, Massachusetts 02453 Phone: 781.314.2936 Fax: 781.314.2999 Key LinksWebsiteInfo Highland Team Bob Higgins
 Graham Gardner, M.D.
|